| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |